In its first results since its insurance unit CEO was fatally shot in New York City, UnitedHealth Group reported Thursday weaker-than-expected fourth-quarter revenue, prompting its shares to fall in early morning trading despite quarterly profit beating projections.
UNH has a split post-earnings history over the last two years, finishing four next-day sessions higher and four lower. The stock also averaged a 4.6% swing, regardless of direction, after its last eight earnings reports. This time around, the options pits are pricing in a bigger 6.9% move.
UnitedHealth is putting pressure on the 30-stock index Thursday after the insurance giant reported a rare revenue miss. This is what you need to know.
UNH stock is finally returning to form after UnitedHealthcare CEO Brian Johnson was gunned down outside an investor meeting in Midtown Manhattan on December 4, leading to a weeklong manhunt that brought light to UnitedHealth’s record of denying health claims and general unpopularity with the public.
UnitedHealth Group ... health provider Amedisys Inc. The Federal Trade Commission is suing the company and two rivals over insulin costs. And a bipartisan group of lawmakers floated legislation ...
U.S. stock indexes are drifting Thursday following a mixed set of earnings reports from Morgan Stanley, UnitedHealth Group and other big companies. The S&P 500 was up 0.2% in early trading. The Dow Jones Industrial Average was up 41 points,
First-quarter earnings season kicks off with results from Citigroup, Goldman Sachs, JPMorgan Chase, Wells Fargo, Bank of America, Morgan Stanley, and UnitedHealth Group.
U.S. stock indexes are rallying toward the close of their best week in two months. The S&P 500 rose 1.1% Friday.
JPMorgan posts record profits, Lululemon raises guidance, Cogeco kickstarts three-year plan, and UnitedHealth beats expectations.
The U.S. Federal Reserve announced on Friday it had withdrawn from a global body of central banks and regulators devoted to exploring ways to police climate risk in the financial system.
The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from price gouging.
Shares were mostly lower in Asia on Friday after China reported that its economy grew at a 5% annual pace last year, hitting the government’s target but slowing from the year before.